GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Organigram Holdings
Organigram is a Canadian cannabis producer. Its share price, like that of its competitors, reflects intense competition, pricing pressure, and slow growth in the Canadian retail market. The stock chart tells the story of the struggle for profitability in a complex and regulated industry.
Share prices of companies in the market segment - Narco food
Organigram Holdings is one of Canada's leading licensed cannabis producers, supplying both the medical and recreational markets. We've classified it as a "Narco-Food" company. The chart below reflects the high volatility and regulatory risks of this growing sector.
Broad Market Index - GURU.Markets
Organigram Holdings is one of Canada's leading licensed cannabis producers, supplying both the medical and recreational markets. We've classified it as a "Narco-Food" company. The chart below reflects the high volatility and regulatory risks of this growing sector.
Change in the price of a company, segment, and market as a whole per day
OGI - Daily change in the company's share price Organigram Holdings
Shares of Organigram, a Canadian cannabis producer, are highly volatile. change_co measures sensitivity to news about legalization and price competition. This metric is the basis for risk analysis in highly regulated consumer sectors on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Narco food
Organigram Holdings Inc. is one of Canada's leading cannabis producers. This chart highlights the sector's extreme volatility. Comparison with OGI's performance helps assess how sensitive its business is to regulatory changes and competition.
Daily change in the price of a broad market stock, index - GURU.Markets
Organigram is a Canadian cannabis company. The sector is characterized by high volatility due to changing regulations and intense competition. The chart below shows average fluctuations in the cannabis industry, reflecting regulatory risks and investor sentiment.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Organigram Holdings
For Organigram Holdings, a Canadian cannabis producer, year-over-year performance is a story of the battle for market share in a competitive market. Its 12-month market cap reflects its success in producing popular strains and derivatives, as well as strategic investments from British American Tobacco, which provide it with financial stability.
Annual dynamics of market capitalization of the market segment - Narco food
Organigram Holdings Inc. is one of Canada's leading cannabis producers. Its performance is heavily dependent on the competitive environment in the Canadian market and the slow progress of legalization in the US. The chart below shows how its efforts to build strong brands and achieve profitability impact its volatility.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Organigram, like other companies in the cannabis market, lives in a world of regulatory news rather than economic cycles. Its stock price is driven not by GDP, but by legalization efforts and its own struggle for profitability in a crowded market. The chart is a story of high hopes and constant disappointments.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Organigram Holdings
The market capitalization of Organigram, a Canadian cannabis producer, reflects the state of the industry. Monthly fluctuations on the chart depend on its ability to grow market share in a highly competitive environment, as well as regulatory policies and investments by major tobacco companies.
Monthly dynamics of market capitalization of the market segment - Narco food
Organigram Holdings is one of Canada's leading licensed cannabis producers. The company grows and sells medical and recreational marijuana. The chart below shows the overall dynamics of the highly volatile cannabis sector, which is dependent on legalization and price competition.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Organigram Holdings is a Canadian cannabis producer. The cannabis industry operates by its own rules: legalization, price competition, and profitability. The company's stock price barely correlates with the broader market, instead following sentiment in its specific and still-emerging sector.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Organigram Holdings
The weekly performance of Organigram, a Canadian cannabis producer, reflects the state of this volatile industry. Its stock price reacts to regulatory changes, sales data, price competition, and news of partnerships, such as with tobacco companies. The chart below shows how short-term events affect the company's valuation.
Weekly dynamics of market capitalization of the market segment - Narco food
How does Organigram's stock compare to the cannabis sector? This chart compares the Canadian producer's weekly performance with the industry average. The analysis reveals whether its response to regulatory news and price competition is typical, or whether its product lineup and partnerships are creating a unique dynamic.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Organigram is one of Canada's licensed cannabis producers. This chart compares its weekly volatility with the market. It shows how much its stock price is influenced by news about regulation, competition, and financial results in the cannabis sector, rather than by overall market trends.
Market capitalization of the company, segment and market as a whole
OGI - Market capitalization of the company Organigram Holdings
The Organigram Holdings price chart reflects the realities of the Canadian cannabis market. The market capitalization of one licensed producer depends on its ability to achieve profitability in a highly competitive environment, oversupply, and strict regulation. The dynamics illustrate this challenging battle for profitability.
OGI - Share of the company's market capitalization Organigram Holdings within the market segment - Narco food
Organigram Holdings Inc. is one of the leading licensed cannabis producers in Canada, holding a significant market share. Its market capitalization reflects its focus on high-quality products and innovation in production.
Market capitalization of the market segment - Narco food
Take a look at the chart: it's the total market capitalization of the cannabis industry. Organigram, as one of Canada's leading producers, is a vital part of this volatile market. The dynamics on the chart reflect regulatory changes, competition, and the slow path to profitability in this emerging sector.
Market capitalization of all companies included in a broad market index - GURU.Markets
This chart is a financial barometer of the Canadian legal cannabis market. The market capitalization of Organigram Holdings, one of the leading licensed producers, reflects the ups and downs of this young industry. The line shows how the cannabis business is struggling to find a stable share of the global consumer economy.
Book value capitalization of the company, segment and market as a whole
OGI - Book value capitalization of the company Organigram Holdings
This chart illustrates the assets of Organigram Holdings, one of Canada's leading licensed cannabis producers. The line represents the combined value of its high-tech indoor greenhouses and processing facilities. The trend shows how the company is investing in its production infrastructure.
OGI - Share of the company's book capitalization Organigram Holdings within the market segment - Narco food
Organigram's physical infrastructure includes its state-of-the-art indoor cannabis cultivation facility and production lines for creating various cannabis-based products. The chart shows the company's share of this high-tech agricultural and production infrastructure, which ensures quality control.
Market segment balance sheet capitalization - Narco food
Below you can see the overall book value of the consumer goods sector. Against this backdrop, Organigram, as a cannabis producer, is capital-intensive. Its business requires the ownership of large, high-tech greenhouses and processing facilities, which contribute to its solid balance sheet.
Book value of all companies included in the broad market index - GURU.Markets
Organigram Holdings is one of Canada's licensed cannabis producers. The company's assets include large, high-tech greenhouses and processing facilities. The company's balance sheet is the value of this complex agro-industrial infrastructure, which creates product for a new, legalized sector of the real economy.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Organigram Holdings
Organigram's balance sheet is the value of its greenhouses and cannabis inventory. A market valuation below book value reflects intense competition, pricing pressure, and investor disillusionment across the industry. The MvsBCap_Co < 1 chart tells the story of how the "green rush" gave way to the harsh realities of life.
Market to book capitalization ratio in a market segment - Narco food
Organigram Holdings is one of Canada's licensed cannabis producers. This chart shows how the market values ββits production capacity, brands, and market share in the highly competitive and regulated market. This value is highly dependent on changes in legislation and consumer preferences.
Market to book capitalization ratio for the market as a whole
Organigram Holdings is one of Canada's licensed cannabis producers. The company's business includes the cultivation, processing, and sale of cannabis products. This chart helps assess how investors view the relatively new and volatile cannabis industry compared to more traditional sectors of the economy.
Debts of the company, segment and market as a whole
OGI - Company debts Organigram Holdings
The debt policy of Organigram, a Canadian cannabis producer, reflects the challenges of a growing but volatile industry. This chart shows how the company uses debt to modernize production facilities, develop new products, and survive a highly competitive and regulatory environment.
Market segment debts - Narco food
Organigram Holdings is one of Canada's licensed cannabis producers. This relatively new industry is characterized by high competition, evolving regulations, and the need to invest in production capacity. This chart shows how the company manages its capital and debt in this emerging, complex market.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Organigram Holdings
Organigram Holdings is one of Canada's licensed cannabis producers. This chart shows the company's financial structure in a young and volatile industry. Its high debt load may be the result of investments in production capacity. This poses a risk in a highly competitive environment, with pricing pressure and changing market regulations.
Market segment debt to market segment book capitalization - Narco food
Organigram Holdings is one of Canada's licensed cannabis producers. The industry faces intense competition and regulatory complexities, requiring effective capital management. The chart shows how the company's debt load compares to the overall market capitalization and financial health of the cannabis sector.
Debt to book value of all companies in the market
Organigram Holdings (OGI) is one of the leading licensed cannabis producers in Canada. This young industry is still searching for sustainable business models. This chart shows the overall market leverage, allowing you to assess how a company in a new and regulated industry manages its capital and debt in a highly competitive environment.
P/E of the company, segment and market as a whole
P/E - Organigram Holdings
This metric for Organigram, a Canadian cannabis producer, reflects the state of this young and volatile industry. P/E ratios are often absent due to losses. The company's valuation depends on cannabis prices, regulatory changes, and its ability to capture market share in a market plagued by oversupply and price competition.
P/E of the market segment - Narco food
This is the average P/E for the cannabis industry, which is often negative. For Organigram, this is an important benchmark. It helps understand how its valuation compares to other Canadian producers, and how investors generally view the prospects of this sector, which is plagued by intense competition and regulatory uncertainty.
P/E of the market as a whole
Organigram Holdings is one of Canada's leading licensed cannabis producers. The company cultivates and sells medical and recreational cannabis, as well as derivative products. This chart, showing overall sentiment, provides an insight into investor sentiment in the still-emerging and volatile cannabis industry.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Organigram Holdings
Organigram is a Canadian licensed producer of cannabis for medical and recreational use. This chart shows expectations for the highly competitive Canadian cannabis market. The valuation depends on the company's ability to manage costs, build strong brands, and adapt to the changing regulatory environment and pricing pressures.
Future (projected) P/E of the market segment - Narco food
Organigram is a Canadian licensed producer of cannabis for medical and recreational use. The chart shows how the company's future profit expectations compare to industry forecasts. This reflects market opinion on the company's ability to achieve profitability and capture significant market share in the highly competitive cannabis market.
Future (projected) P/E of the market as a whole
Organigram Holdings is a Canadian cannabis producer. Its business is dependent on the regulatory environment, competition, and consumer demand for legal marijuana. This chart of overall market expectations is important as an indicator of investor appetite for risky and emerging sectors. Growing optimism could attract capital to the cannabis industry.
Profit of the company, segment and market as a whole
Company profit Organigram Holdings
Organigram is one of Canada's leading licensed cannabis producers. The company cultivates and sells recreational and medical cannabis. Its profits depend on product pricing, competition in the saturated Canadian market, and opportunities to expand into international markets.
Profit of companies in the market segment - Narco food
Organigram is one of Canada's licensed cannabis producers. The company's profitability depends on pricing, competition, and the regulatory environment in this young and volatile market. This chart reflects the complexities of establishing a new legal industry, where initial excitement gives way to a fierce battle for profitability and consolidation among players.
Overall market profit
Organigram Holdings is one of Canada's licensed cannabis producers. The company's growth depends on the development of the legal market, the regulatory environment, and its ability to compete with other producers. This sector has its own dynamics, which may not align with the general economic cycles reflected in this chart.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Organigram Holdings
Organigram Holdings is one of the leading licensed cannabis producers in Canada. The future profit projections shown in this chart depend on the state of the Canadian recreational cannabis market, the company's ability to maintain market share, and the efficiency of its production operations. Competition and pricing pressure are key factors.
Future (predicted) profit of companies in the market segment - Narco food
Organigram Holdings is a Canadian licensed producer of cannabis for medical and recreational use. This chart shows the profit forecast for the entire cannabis industry. It reflects expectations for market growth, competition, and the regulatory environment. This context is key for assessing Organigram's operational performance and path to sustainable profitability.
Future (predicted) profit of the market as a whole
Organigram Holdings is one of Canada's licensed cannabis producers. Demand for its products depends on consumer spending on recreational products and market developments. The overall economic forecasts presented here impact discretionary income, which is the source of profit for companies in this industry.
P/S of the company, segment and market as a whole
P/S - Organigram Holdings
Organigram is one of Canada's licensed cannabis producers. The company grows and sells marijuana for medical and recreational use. This chart shows how investors view its revenue in the highly competitive and highly regulated Canadian market, which has yet to meet initial expectations.
P/S market segment - Narco food
Organigram Holdings is one of Canada's leading licensed cannabis producers. The company cultivates and sells medical and recreational cannabis, as well as derivative products such as oils and chocolate. This chart shows the average market valuation for the sector, helping to understand how the market views Organigram's brand and operational performance in the competitive cannabis market.
P/S of the market as a whole
Organigram Holdings is one of Canada's leading licensed cannabis producers. The company cultivates and sells medical and recreational cannabis, operating in a volatile and evolving market. This chart helps investors compare how the market values ββthe company's revenue in a specialized and regulated industry against more traditional sectors.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Organigram Holdings
Organigram is a Canadian cannabis producer. The company's future revenue depends on the growth of the legal cannabis market, its market share, and its ability to produce in-demand products. This chart reflects investor expectations for the development of this young and volatile industry.
Future (projected) P/S of the market segment - Narco food
Organigram Holdings is one of the leading licensed cannabis producers in Canada. This chart compares the company's estimated future sales with other edibles producers. It shows how investors view its focus on quality products and its ability to compete in the challenging Canadian market.
Future (projected) P/S of the market as a whole
Organigram is one of Canada's licensed cannabis producers. The company's success depends on the growth of the legal market, the regulatory environment, and consumer preferences. General economic optimism, reflected in this chart, may indirectly influence consumers' willingness to spend on such products and investor appetite for this growing industry.
Sales of the company, segment and market as a whole
Company sales Organigram Holdings
Organigram Holdings is one of the leading licensed cannabis producers in Canada. The company's revenue is generated by the sale of recreational and medical cannabis in various forms, from dried flower to oils and edibles. The chart shows sales volumes in the competitive Canadian cannabis market.
Sales of companies in the market segment - Narco food
Organigram Holdings is one of the leading licensed cannabis producers in Canada. The company grows and sells a wide range of products, including dried flower, oils, and edibles, to both the medical and recreational markets. This chart illustrates the competitive Canadian cannabis market, where production efficiency and brand strength are key to success.
Overall market sales
Organigram is a Canadian cannabis producer. Demand for its products depends on legalization, consumer preferences, and competition. This curve, reflecting overall consumer spending, influences how much people are willing to spend on recreational products, including cannabis, making the industry sensitive to economic cycles.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Organigram Holdings
Organigram is one of the leading licensed cannabis producers in Canada. The company operates in a highly competitive and regulated market where profitability remains challenging. This chart shows analyst expectations for the Canadian cannabis market growth and Organigram's ability to increase its market share and achieve profitability.
Future (projected) sales of companies in the market segment - Narco food
Organigram Holdings is one of Canada's licensed cannabis producers. This chart illustrates expectations for the entire cannabis industry. It helps analyze how the company is navigating the intense competition, pricing pressure, and evolving regulations in the Canadian market while simultaneously seeking to expand into international markets.
Future (projected) sales of the market as a whole
Organigram Holdings is one of Canada's licensed cannabis producers. This chart, reflecting consumer spending on recreational products, is important to the company. Rising disposable incomes and changing public attitudes toward cannabis impact sales volumes, while the overall economic climate determines the investment climate in the industry.
Marginality of the company, segment and market as a whole
Company marginality Organigram Holdings
Organigram Holdings is one of the leading licensed cannabis producers in Canada. The company's profitability depends on cultivation efficiency, product pricing, and the strength of its brands in a competitive market. This chart shows how successfully the company manages its operations to turn cannabis production into a profitable business.
Market segment marginality - Narco food
Organigram Holdings is one of Canada's licensed cannabis producers. Profitability in this young and competitive industry depends on cultivation efficiency, brand strength, and the ability to introduce new products (e.g., beverages, edibles). This chart shows how Organigram compares to other producers in these areas.
Market marginality as a whole
Organigram Holdings is one of Canada's leading licensed cannabis producers. Despite the general picture of profitability, their business is a struggle to stay profitable in a crowded and highly regulated market. Their success depends on brand strength, operational efficiency, and the ability to develop new, in-demand products, such as edibles.
Employees in the company, segment and market as a whole
Number of employees in the company Organigram Holdings
Organigram is one of the leading licensed cannabis producers in Canada. This graph shows the large team involved in growing, processing, and packaging. The size of the team is a direct indicator of the company's production capacity and ability to compete in the saturated Canadian market.
Share of the company's employees Organigram Holdings within the market segment - Narco food
Organigram Holdings is one of the leading licensed cannabis producers in Canada. This chart demonstrates the company's clout in the cannabis industry. It illustrates the number of specialists, from agronomists to quality control specialists, that Organigram brings together to produce a wide range of products for the medical and recreational markets.
Number of employees in the market segment - Narco food
Organigram Holdings is one of the leading licensed cannabis producers in Canada. This chart shows employment trends in the cannabis industry. The fluctuations in headcount reflect the intense competition, pricing pressure, and regulatory changes in the Canadian market following legalization, which pose challenges for all producers in the sector.
Number of employees in the market as a whole
Organigram Holdings is one of the leading licensed cannabis producers in Canada. The company produces products for both the medical and recreational markets. This chart shows overall employment, and cannabis legalization has led to the emergence of an entirely new industry with thousands of jobs in agritech, manufacturing, distribution, and retail.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Organigram Holdings (OGI)
Organigram Holdings Inc. is a Canadian cannabis producer. This business combines capital-intensive agriculture (cultivation) with consumer goods manufacturing. This chart shows a moderate capitalization per employee. Value is generated through brands and production facilities, but operating greenhouses and factories requires a significant workforce.
Market capitalization per employee (in thousands of dollars) in the market segment - Narco food
Organigram Holdings is one of the leading licensed cannabis producers in Canada. In this relatively new industry, this metric reflects production efficiency, brand strength, and ability to operate in a regulated market. The chart compares how well the company creates value per employee compared to its competitors.
Market capitalization per employee (in thousands of dollars) for the overall market
Organigram Holdings is one of Canada's licensed cannabis producers. The company operates in a young and volatile industry. This chart shows how the market evaluates each employee's ability to effectively grow, process, and sell products in a highly competitive and increasingly regulated environment.
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Organigram Holdings (OGI)
Organigram (OGI) is one of Canada's leading licensed cannabis producers. In this young and volatile industry, this chart shows operational efficiency. It measures how much profit (or loss) each employee, from agronomist to packager, generates amid a price war and oversupply.
Profit per employee (in thousands of dollars) in the market segment - Narco food
Organigram Holdings is one of the leading licensed cannabis producers in Canada. Their business is focused on high-tech agriculture. This chart represents an industry benchmark. It helps assess how effectively Organigram manages its production and personnel in the highly competitive Canadian market.
Profit per employee (in thousands of dollars) for the market as a whole
Organigram Holdings is one of the leading licensed cannabis producers in Canada. It's essentially high-tech agriculture combined with rigorous pharmaceutical manufacturing. Profit per employee in this industry is a measure of efficiency. It reflects the technological advancements (e.g., three-tiered grow rooms) and the cost effectiveness of the company's cultivation and processing capabilities.
Sales to employees of the company, segment and market as a whole
Sales per company employee Organigram Holdings (OGI)
Organigram is a Canadian licensed cannabis producer. This chart shows productivity in a young and volatile industry. Revenue per employee depends on production volume, wholesale cannabis prices, and the company's ability to create and sell branded products with higher margins, such as oils and edibles.
Sales per employee in the market segment - Narco food
Organigram (OGI) is one of Canada's leading licensed cannabis producers. They produce both cannabis itself and cannabis-derived products (oils, edibles). This chart shows how much revenue each employee generates from product sales. It's an indicator of their production efficiency and brand strength in the competitive cannabis market.
Sales per employee for the market as a whole
Organigram Holdings is one of Canada's licensed cannabis producers. They cultivate and sell recreational and medical cannabis. This agribusiness requires large greenhouses and staff. This chart shows how efficiently the company generates revenue in the highly competitive and overproduced Canadian cannabis industry, where prices are under pressure.
Short shares by company, segment and market as a whole
Shares shorted by company Organigram Holdings (OGI)
Organigram Holdings is one of Canada's licensed cannabis producers. This chart shows bearish bets. The shorts are driven by the Canadian market's challenges: oversupply, a black market, low margins, and slow growth. Investors fear the company will be unable to achieve profitability under these conditions.
Shares shorted by market segment - Narco food
Organigram (OGI) is one of the leading licensed cannabis producers in Canada. This chart shows the bets against the entire cannabis sector. The rising bets against the industry reflect deep investor pessimism: the Canadian market is oversaturated, prices are falling, and federal legalization in the US (their main hope) is continually delayed, preventing OGI from achieving profitability.
Shares shorted by the overall market
Organigram Holdings (OGI) is a Canadian cannabis producer. The sector is known for its intense competition, regulatory issues, and unprofitability. It's a speculative asset. When this chart shows rising fear, investors are quick to dump stocks in hyped but unprofitable sectors, and OGI is a prime example.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Organigram Holdings (OGI)
Organigram Holdings is a Canadian cannabis producer. The business faces high sector risks (regulation, competition, pricing). A chart above 70 may reflect positive legalization news or strong selling. A level below 30 is often associated with price wars, regulatory pressure, or a general downturn in the cannabis sector.
RSI 14 Market Segment - Narco food
Organigram is one of the leading licensed cannabis producers in Canada. Like the entire industry, the company struggles to remain profitable in a highly competitive and regulated market. This chart shows the overall "temperature" of the entire speculative cannabis sector. It clearly demonstrates when the entire industry is overheated by expectations of legalization or oversold amid price wars.
RSI 14 for the overall market
Organigram (OGI), a cannabis producer, is pure speculation, as reflected in this chart. During periods of market euphoria, investors are willing to "buy the dream" and invest in the "future." During moments of panic (and in the absence of legalization), investors flee unprofitable "concepts," and these stocks are the first to be sold off.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast OGI (Organigram Holdings)
Organigram is one of the leading licensed cannabis producers in Canada. This chart shows the average target price. Analysts' forecasts are based on the company's market share in Canada, sales growth (including edibles), and expectations for international legalization (US, Germany).
The difference between the consensus estimate and the actual stock price OGI (Organigram Holdings)
Organigram (OGI) is a Canadian cannabis producer (LP) struggling to achieve profitability in a crowded Canadian market. This chart is a barometer of those hopes. It measures the gap between the price and the consensus target, reflecting whether analysts believe they can survive and see legalization in the US, based on BAT's investment.
Analyst consensus forecast for stock prices by market segment - Narco food
Organigram Holdings (OGI) is one of Canada's leading licensed cannabis producers, having received investment from British American Tobacco. This chart shows analysts' overall expectations for the cannabis sector, reflecting whether experts believe the Canadian market will consolidate and survive.
Analysts' consensus forecast for the overall market share price
Organigram Holdings is one of the leading licensed cannabis producers in Canada. This chart shows overall risk appetite. For Organigram, which operates in the volatile cannabis sector, dependent on legalization and intense competition, overall market optimism is important, but regulatory news in the US and Canada carries far more weight than general sentiment.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Organigram Holdings
Organigram (OGI) is one of Canada's leading licensed cannabis producers (LPs). They are known for their three-tiered indoor production facility and focus on premium products. This chart is a barometer of the Canadian cannabis market. It reflects their market share, their ability to navigate the price war, and their arduous journey to achieving sustainable profitability.
AKIMA Market Segment Index - Narco food
Organigram Holdings is one of the leading licensed cannabis producers in Canada. The company operates in a volatile and highly competitive market. This chart shows the average index for the segment. It allows investors to assess how effectively Organigram manages production and distribution compared to the industry average.
The AKIM Index for the overall market
Organigram is a Canadian cannabis producer known for its high-quality indoor cultivation and innovation. This chart, which reflects the market average, provides a macro backdrop. It helps assess how Organigram, surviving in the competitive Canadian cannabis sector, fares against the backdrop of the overall economic situation and regulatory expectations.